Skip to main content

Table 2 univariate and multivariate analysis of predictors of CVA

From: Effect of congenital heart disease on the recurrence of cough variant asthma in children

Variables

Univariate analysis

Multivariate analysis

HR (95%CI)

P value

aHR (95%CI)

P value

CHD

    

CCHD

3.237 (1.655–6.331)

0.001

3.281 (1.648–6.530)

0.001

SCHD

2.293 (1.575–3.339)

0.000

2.555 (1.739–3.752)

0.000

No

1

 

1

 

Age (year)

  

 

 1–3

0.985 (0.652–1.488)

0.944

 

 4–6

1.153 (0.739–1.797)

0.531

 

 7–14

1

 

 

Male

1.132 (0.800–1.602)

0.484

 

Family history of allergies

0.731 (0.427–1.253)

0.254

 

Elevated eosinophil ratio

1.066 (0.736–1.544)

0.734

 

Mycoplasma pneumonia positive

2.557 (1.770–3.694)

0.000

2.172 (1.482–3.184)

0.000

sIgE sensitization

1.941 (1.324–2.845)

0.001

1.777 (1.188–2.657)

0.005

Standardized treatment

0.875 (0.216–3.539)

0.851

 
  1. aHR indicates multiple analysis, including CHD classification, MP infection and IgE sensitization
  2. CHD congenital heart disease, CVA cough variant asthma, SCHD simple congenital heart disease, CCHD complex congenital heart disease, sIgE Serum-specific immunoglobulin E, HR hazard ratio, aHR adjusted hazard ratio, MP mycoplasma pneumoniae